Feature | March 20, 2012

SCAI Publishes Best Practices for Cath Labs

March 20, 2012 – The Society for Cardiovascular Angiography and Interventions (SCAI) published a first-of-its-kind paper defining best practices in the cardiac catheterization laboratory, commonly referred to as the cath lab. The paper is part of SCAI’s ongoing effort aimed to ensure the highest quality care and safety for patients undergoing interventional cardiology procedures such as angioplasty and stenting (also known as percutaneous coronary intervention or PCI). Titled “Clinical Expert Consensus Statement on Best Practices in the Cardiac Catheterization Laboratory,” the paper is e-published in Catheterization and Cardiovascular Interventions.

Just as a surgical suite serves patients requiring surgery, cath labs support procedures that require catheterization, whereby a small, flexible tube called a catheter is inserted into an artery in the patient’s upper leg or wrist to access the heart arteries and clear blockages. The cath lab is where heart attacks are stopped and where patients suffering from various forms of heart disease are treated for symptom relief and improvements in quality of life.

“Interventional cardiologists are guided by a number of quality improvement tools, including guidelines and appropriate use criteria, but consensus opinion on best practices for how to run these cath labs has been missing until now,” said Srihari S. Naidu, M.D., FSCAI, SCAI trustee and director of the cardiac catheterization laboratory at Winthrop University Hospital, Long Island, NY, and lead author of the paper. “This paper represents the most current, evidence-based approach to continually improving the safety and care of interventional cardiology patients in cath labs across the country and the world.”
The paper published recommends best practices that should be upheld by interventional cardiologists and other medical staff performing procedures in the cath lab setting. The best practices are divided into three categories: before the procedure, during and after the procedure, including follow-up evaluation, and feature the following highlights:

  • Assembling an optimal cardiac catheterization team. Physicians should maintain proper credentialing and other members of the medical staff should also have the proper certifications and experience. In addition, procedure outcomes, including success rates and observed complications, should be documented.
  • A pre-procedure checklist for cardiac catheterization that guides the attending physician through a list of questions to review and verify prior to initiating the procedure. A common tool used in other medical specialties, the checklist includes affirmation of the procedure type, pre-catheterization assessments, as well as reviewing the patient’s health history, ability to adhere to medication regimens, informed consent, sedation, and allergies.
  • Receiving informed consent. Included within pre-procedure best practices is the importance of receiving informed consent from the patient, ideally with a third-party witness. The paper points out the importance of verifying the patient fully understands what the procedure entails; the risks, benefits and alternatives to the treatment proposed; as well as potential outcomes and complications that may occur during and after the procedure.
  • A recommended “time out” protocol to be performed immediately before the procedure and when all members of the medical team are present. During this “time out” period, patient identification is verified, as is procedure route, procedure equipment, patient allergies and special medical conditions.
  • Patient preparation in the procedure room. Best practices during the procedure include a thorough review of the patient’s medical record, access site concerns, allergies, blood test results, recent medications, advance directives, informed consent and living wills.
  • Appropriate post-procedure communications and evaluation. Following the procedure, the patient must be carefully monitored during the hospital stay. The physician should discuss the results of the procedure, as well as complications, unexpected findings and events with the patient and family as well as with the healthcare providers who will assume care of the patient. The physician should also explain the important role of patient adherence with prescribed medications.
  • Planned follow up. Best post-procedure practices include scheduling the patient’s follow-up appointment two to four weeks after discharge to confirm the access site is healing, ascertain that there are no medication complications or problems with adherence, evaluate current lifestyle limitations and enroll in cardiac rehabilitation.
  • Quality assurance protocols. Each cardiac cath lab should have processes in place for nonbiased, education-based peer review of procedures. “SCAI’s commitment to quality improvement is unwavering, and we are confident this paper will only serve to improve cath labs and the work we do for our patients,” said Christopher J. White, M.D., FSCAI, SCAI president and professor and system chairman of cardiovascular diseases at the John Ochsner Heart & Vascular Institute, New Orleans, La. “This paper will provide a benchmark for cath labs to base their current practices on and help set future goals elevating the standard of patient care across the practice.”


“Clinical Expert Consensus Statement on Best Practices in the Cardiac Catheterization Laboratory,” along with the full issue of Catheterization and Cardiovascular Interventions, is available via www.scai.org.

Related Content

bioresorbable stents, bioabsorbable stents, visualizing the Absorb BVS, dissolving stent, disappearing stent on IVUS and OCT

A comparison of how the Abbott Absorb BVS appears with intravascular ultrasound (IVUS) on the left, and optical coherence tomography (OCT) of the right. The stent is difficult to visualize and sizing is critical, so both modalities can help in bioresorbable stent measurements and to confirm stent apposition. Left image from the Volcano IVUS system and the right image from St. Jude Medical's OCT system


Feature | Stents Bioresorbable| October 20, 2016 | Dave Fornell
There has been a lot of interest in the interventional community regarding the Abbott Absorb Bioresorbable Vascular S
Avinger, Pantheris atherectomy catheter, OCT, Lumivascular technology, expanded FDA indication, diagnostic imaging device
News | Atherectomy Devices| October 20, 2016
Avinger Inc. recently announced that the company has received expanded indications from the U.S. Food and Drug...
recall, alligator retrieval device, X-Celerator hydrophilic guidewire, UltraFlow flow directed micro catheters, Marathon flow directed micro catheters
News | Cath Lab| October 18, 2016
Medtronic plc announced last week that it has notified customers of a voluntary recall of certain lots of its Pipeline...
Inventory management, Cardinal, RFID inventory tracking, cath lab inventory
Sponsored Content | Whitepapers | Inventory Management| October 18, 2016
As healthcare moves into the era of bundled payments, providers need to be especially focused on ensuring delivery of
angioseal, angio-seal, terumo, St. Jude, vascular closure devices
News | Vascular Closure Devices| October 18, 2016
October 18, 2016 — Abbott and St. Jude Medical Inc.
3-D bioprinting, 3-D printing, printed organs, 3D bioprinting

3-D printed vessel made from living cells implanted in an animal to test feasibility of using such structures clinically. Blood vessels are a stepping stone to the creation of more complex 3-D printed organs made from biomaterials. Image from the South Carolina Project for Organ Biofabrication.


Feature | 3-D Printing| October 13, 2016 | Dave Fornell
The U.S. Food and Drug Administration (FDA) changed its rules concerning custom medical devices Oct.
Shockwave lithoplasty system, VIVA 16, Vascular Interventioanl Advances, VIA Physicians, late-breaking endovascular clinical trial results
News | Cath Lab| October 12, 2016
VIVA (Vascular Interventional Advances) Physicians announced a number of highly anticipated late-breaking clinical...
Terumo Finecross, guidewires, guide wires, guidewires 101, basics of guidewire technology

An illustration of Terumo's Finecross guidewire crossing a tight lesion. 

Feature | Guidewires| October 12, 2016 | Dave Fornell
While guidewires are a key tool used by
Medtronic, FDA clearance, TrailBlazer peripheral angled support catheter, PAD, peripheral artery disease
Technology | Peripheral Arterial Disease (PAD)| October 12, 2016
Medtronic plc announced recently that the U.S. Food and Drug Administration (FDA) has cleared the TrailBlazer angled...
Cardioband, first tricuspid valve repair, University Hospital Zurich, Francesco Maisano
News | Heart Valve Technology| October 10, 2016
Francesco Maisano, clinic director at the University Hospital Zurich, recently led a team of cardiac surgeons and...
Overlay Init